Cite

HARVARD Citation

    Priceman, S. et al. (2015). Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online]. 
  
Back to record